Cargando…

CK1δ Kinase Activity Is Modulated by Chk1-Mediated Phosphorylation

CK1δ, a member of the casein kinase 1 family, is involved in the regulation of various cellular processes and has been associated with the pathophysiology of neurodegenerative diseases and cancer. Therefore recently, interest in generating highly specific inhibitors for personalized therapy has incr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bischof, Joachim, Randoll, Sven-Jannis, Süßner, Nadine, Henne-Bruns, Doris, Pinna, Lorenzo A., Knippschild, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701638/ https://www.ncbi.nlm.nih.gov/pubmed/23861943 http://dx.doi.org/10.1371/journal.pone.0068803

Ejemplares similares

Comprehensive Characterization of CK1δ-Mediated Tau Phosphorylation in Alzheimer’s Disease
por: Roth, Aileen, et al.
Publicado: (2022)

Microtubules Depolymerization Caused by the CK1 Inhibitor IC261 May Be Not Mediated by CK1 Blockage
por: Stöter, Martin, et al.
Publicado: (2014)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

Neurite Outgrowth of Mature Retinal Ganglion Cells and PC12 Cells Requires Activity of CK1δ and CK1ε
por: Bischof, Joachim, et al.
Publicado: (2011)

CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP
por: Roth, Aileen, et al.
Publicado: (2021)

Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines
por: Liu, Congxing, et al.
Publicado: (2019)

CK1α overexpression correlates with poor survival in colorectal cancer
por: Richter, Julia, et al.
Publicado: (2018)

Impaired CK1 Delta Activity Attenuates SV40-Induced Cellular Transformation In Vitro and Mouse Mammary Carcinogenesis In Vivo
por: Hirner, Heidrun, et al.
Publicado: (2012)

2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε
por: Bischof, Joachim, et al.
Publicado: (2012)

CK1 Is a Druggable Regulator of Microtubule Dynamics and Microtubule-Associated Processes
por: Roth, Aileen, et al.
Publicado: (2022)

A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1ε
por: Dolde, Christine, et al.
Publicado: (2018)

Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK
por: Halekotte, Jakob, et al.
Publicado: (2017)

Assessing the Inhibitory Potential of Kinase Inhibitors In Vitro: Major Pitfalls and Suggestions for Improving Comparability of Data Using CK1 Inhibitors as an Example
por: Roth, Aileen, et al.
Publicado: (2021)

The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis
por: Knippschild, Uwe, et al.
Publicado: (2014)

c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1
por: Tian, Xiaodong, et al.
Publicado: (2021)

Immunohistochemical Characterisation of Cell-Type Specific Expression of CK1δ in Various Tissues of Young Adult BALB/c Mice
por: Löhler, Jürgen, et al.
Publicado: (2009)

Site-specific phosphorylation of casein kinase 1 δ (CK1δ) regulates its activity towards the circadian regulator PER2
por: Eng, Gracie Wee Ling, et al.
Publicado: (2017)

CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions
por: Giamas, Georgios, et al.
Publicado: (2009)

Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment
por: Martínez-González, Loreto, et al.
Publicado: (2020)

Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain
por: Ottaviani, Daniele, et al.
Publicado: (2017)

Activation of p53: How phosphorylated Ser15 triggers sequential phosphorylation of p53 at Thr18 by CK1δ
por: Nicolaou, Sonia T., et al.
Publicado: (2022)

Comparison of Different Risk Classification Systems in 558 Patients with Gastrointestinal Stromal Tumors after R0-Resection
por: Schmieder, Michael, et al.
Publicado: (2016)

CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma
por: Burger, Karen L., et al.
Publicado: (2023)

Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls
por: Hillenbrand, Andreas, et al.
Publicado: (2012)

Zebrafish as model system for the biological characterization of CK1 inhibitors
por: Meier, Laura, et al.
Publicado: (2023)

Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity
por: Walker, M, et al.
Publicado: (2009)

Fuzzy interactions between the auto-phosphorylated C-terminus and the kinase domain of CK1δ inhibits activation of TAp63α
por: Lambert, Mahil, et al.
Publicado: (2023)

CHK1 phosphorylates PRIMPOL to promote replication stress tolerance
por: Mehta, Kavi P. M., et al.
Publicado: (2022)

γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
por: Rawlinson, Rebecca, et al.
Publicado: (2014)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

Role for casein kinase 1 in the phosphorylation of Claspin on critical residues necessary for the activation of Chk1
por: Meng, Zheng, et al.
Publicado: (2011)

The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
por: García-Reyes, Balbina, et al.
Publicado: (2018)

CK1δ/ε protein kinase primes the PER2 circadian phosphoswitch
por: Narasimamurthy, Rajesh, et al.
Publicado: (2018)

Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients
por: Hillenbrand, Andreas, et al.
Publicado: (2010)

Circulating adipokine levels and prognostic value in septic patients
por: Hillenbrand, Andreas, et al.
Publicado: (2016)

Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
por: Kretz, Anna-Laura, et al.
Publicado: (2018)

TRAILblazing Strategies for Cancer Treatment
por: Kretz, Anna-Laura, et al.
Publicado: (2019)

Stress-activated kinases as therapeutic targets in pancreatic cancer
por: Traub, Benno, et al.
Publicado: (2021)

Casein Kinase 1 Family Member CK1δ/Hrr25 Is Required for Autophagosome Completion
por: Li, Yuting, et al.
Publicado: (2020)

Association of adiponectin levels and insulin demand in critically ill patients
por: Hillenbrand, Andreas, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5c41omolmar9ivgmq8sruj48om